3 Key Takeaways
Plain English Summary- 01Core Finding
Its pathophysiology involves an interplay of genetic susceptibility, environmental exposures, and epigenetic modifications that disrupt immune tolerance, promoting T-cell mediated thyroid injury and thyroid autoantibody production.
- 02Study Evidence
Tested in a observational cohort study at the real-world cohort stage.
- 03Practical Meaning
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.
What This Means for You
Management centres on levothyroxine replacement for overt hypothyroidism, with an individualised approach to subclinical disease. Thyroidectomy is reserved for selected indications, whereas emerging immunomodulatory strategies remain investigational.
This Review synthesises developments over the past two decades in the epidemiology, natural history, aetiopathogenesis, diagnosis, and management of Hashimoto's thyroiditis, and considers emerging mechanistic insights and approaches to precision medicine that might inform future disease-modifying therapies.
The Discovery
Hashimoto's thyroiditis is the most common cause of primary hypothyroidism in iodine-sufficient regions and is characterised by immune-mediated injury to thyroid follicular cells. Its pathophysiology involves an interplay of genetic susceptibility, environmental exposures, and epigenetic modifications that disrupt immune tolerance, promoting T-cell mediated thyroid injury and thyroid autoantibody production. The disease can progress from euthyroid autoimmunity to subclinical and overt hypothyroidism, with substantial variation in its course. Clinical manifestations vary with the extent of thyroid dysfunction and inflammatory activity. Diagnosis relies on clinical assessment, thyroid function testing, thyroid autoantibody measurement, and ultrasonography when indicated.
How It Works, Simply
This endocrinology research focuses on inflammation · T cells · Immune response. Researchers evaluated it using an observational cohort study at the real-world cohort stage of medical research.
3 Key Takeaways
Clinical Takeaways- 01Core Finding
Its pathophysiology involves an interplay of genetic susceptibility, environmental exposures, and epigenetic modifications that disrupt immune tolerance, promoting T-cell mediated thyroid injury and thyroid autoantibody production.
- 02Study Evidence
Tested in a observational cohort study at the real-world cohort stage.
- 03Practical Meaning
Observational cohort findings reveal real-world links, though lifestyle or unmeasured factors cannot be fully ruled out without an RCT.
Biological Mechanism & Study Design
Study Design & Cohort
Observational cohort study
Observational cohort study · Real-World Cohort
Biological Pathway & Modality
Inflammation · T cells · Immune response
Intervention: Hashimoto's thyroiditis: two decades on
Experimental Findings & Endpoints
Hashimoto's thyroiditis is the most common cause of primary hypothyroidism in iodine-sufficient regions and is characterised by immune-mediated injury to thyroid follicular cells.
Its pathophysiology involves an interplay of genetic susceptibility, environmental exposures, and epigenetic modifications that disrupt immune tolerance, promoting T-cell mediated thyroid injury and thyroid autoantibody production. The disease can progress from euthyroid autoimmunity to subclinical and overt hypothyroidism, with substantial variation in its course.
Clinical manifestations vary with the extent of thyroid dysfunction and inflammatory activity. Diagnosis relies on clinical assessment, thyroid function testing, thyroid autoantibody measurement, and ultrasonography when indicated.
Clinical Translation & Practice Context
Management centres on levothyroxine replacement for overt hypothyroidism, with an individualised approach to subclinical disease.
Thyroidectomy is reserved for selected indications, whereas emerging immunomodulatory strategies remain investigational.
This Review synthesises developments over the past two decades in the epidemiology, natural history, aetiopathogenesis, diagnosis, and management of Hashimoto's thyroiditis, and considers emerging mechanistic insights and approaches to precision medicine that might inform future disease-modifying therapies.
The Bottom Line · Clinical Pearl
“This Review synthesises developments over the past two decades in the epidemiology, natural history, aetiopathogenesis, diagnosis, and management of Hashimoto's thyroiditis, and considers emerging mechanistic insights and approaches to precision medicine that might inform future disease-modifying therapies.”
Published in The Lancet Diabetes & Endocrinology · Current Stage: Real-World Cohort